Brandon Yaras
Chief Financial Officer · aTYR PHARMA INC
Individual
- 2026
- Oct 1, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brandon Yaras files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul Schimmel - $50K in ATYR purchases and sales in the last 12 months
- Sanjay Shukla - $4K in ATYR purchases and sales in the last 12 months
- Jill Marie Broadfoot - $2K in ATYR purchases and sales in the last 12 months
- Nancy Denyes - $1K in ATYR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brandon Yaras?
Brandon Yaras is a corporate insider, tracked as Chief Financial Officer of aTYR PHARMA INC (ATYR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brandon Yaras submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.